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Objective: Wound infections after cardiac surgery carry high morbidity and mor-
tality. A plethora of management strategies have been used to treat such infections.
We assessed the impact of vacuum-assisted closure on the management of sternal
wound infections in terms of wound healing, duration of vacuum-assisted closure,
and cost of treatment.
Methods: Between November 1998 and June 2001, a total of 27 mediastinal
infections were managed with vacuum-assisted closure. Group A (n  14) had
vacuum-assisted closure as the final treatment modality, whereas in group B (n 
13) vacuum-assisted closure was followed by either a myocutaneous flap (n  8) or
primary (n  5) wound closure. The choice of additional treatment modality was
based on wound size.
Results: In group A, 4 patients died and a satisfactorily healed scar was achieved in
64% of cases. Median durations of vacuum-assisted closure and hospital stay in
group A were 13.5 days (interquartile range 8.8-32.2 days) and 20 days (interquar-
tile range 16.7-25.2 days), respectively. Mortality was 7.7% in group B, with a
treatment failure rate of 15%. Median duration of vacuum-assisted closure in group
B was 8 days (interquartile range 5.5-18 days), and median hospital stay was 29
days (interquartile range 25.8-38.2 days). During the year before institution of
vacuum-assisted closure, poststernotomy infection (n  13) was managed with
rewiring and closed irrigation system. Treatment during this year failed in 30.7% of
cases (n  4/13), and mortality was also 30.7%. The total cost (hospitalization and
treatment) per patient for vacuum-assisted closure was $16,400, compared with
$20,000 for the closed irrigation system treatment.
Conclusion: Vacuum-assisted closure, used alone or before other surgical treatment
strategies, is an acceptable treatment modality for infections in cardiac surgery with
reasonable morbidity, mortality, and cost.
Even a century after the initial description of the median sternotomyapproach to the heart,1 there is still no consensus regarding thetreatment of poststernotomy mediastinitis. Fortunately, this is a rarecomplication, albeit one that carries high morbidity and mortality.2Previously described management strategies for poststernotomy me-diastinitis include the following in varying combinations: antibiotic
therapy, wound incision and drainage, de´bridement, rewiring, closed irrigation,
packing, delayed closure, and omental and myocutaneous flap reconstruction.3 A
newly emerging treatment that has been added to this eclectic approach involves the
use of vacuum-assisted closure (VAC),4 which has been described in only a handful
of patients.4-6 We contribute to this literature by describing our experience with
VAC in a series of 27 patients with poststernotomy mediastinitis.
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Methods
Between November 1998 and June 2001, a total of 27 out of 491
(0.05) patients who underwent cardiac surgery through a median
sternotomy by a specific surgeon (A.J.R.) acquired sternal wound
infections that were treated with the VAC technique (KCI Medical
Ltd, Whitney, United Kingdom) either as definitive therapy (group
A) or followed by a second procedure (group B). Initially, the
intended treatment was VAC only. In 8 cases, however, the wound
defect was quite large, and use of VAC alone for healing would
have meant a much longer hospitalization. These patients therefore
underwent myocutaneous flap closure, because the wound was
“clean” and granulating after VAC application. Similarly, 5 pa-
tients underwent direct wound closure after VAC because this
facilitated their discharge from the hospital.
Sternal wound infection was defined by positive results of
microbial culture, persistent pyrexia in the setting of neutrophilia,
or clinical evidence of sepsis. Antibiotic therapy was selected
according to the sensitivity of the organism and the clinical re-
sponse of the patient.
Statistics
Data are expressed as mean  SD, as median with interquartile
range, or as percentage of patients.
Results
Wound infections developed in patients undergoing coro-
nary artery bypass grafting either alone (n  17) or in
combination with aortic valve replacement (n  6). In the
remaining patients the initial surgical procedures were aor-
tic valve replacement (n  2), pulmonary thromboendarter-
ectomy (n  1), and transplantation (n  1). In 18 cases
(66%), VAC application was preceded by sternal wound
de´bridement (group A n  8, group B n  10).
In group A, 21% of the patients had diabetes, and left
internal thoracic artery was used in 86% of the cases. Mean
body mass index was 30.9  3.7 kg/m2. None of the
patients in group A were receiving immunosuppressive
therapy. A single infectious agent was isolated in 62% of
cases. Methicillin-resistant Staphylococcus aureus was cul-
tured in 3 patients (21%) in group A, either alone or along
with other bacteria. Infection was diagnosed at a median of
7.5 days (interquartile range 5.8-12.8 days) after the oper-
ation (incubation period). The duration of the VAC treat-
ment was a median of 13.5 days (interquartile range 8.8-
32.2 days). A healed scar was achieved in 76% of cases, but
because of in-hospital deaths among these patients (not
related to the wound problem), overall only 64% of patients
survived with a satisfactorily healed scar. Of the remainder,
1 patient had a chronic persistent discharge from the sternal
wound despite other therapy and a further 2 patients died in
the hospital with multiorgan failure (total death rate 28.6%).
Two patients were discharged home with a battery-powered
mini VAC. They were followed up in the outpatient depart-
ment. The median hospital stay was 20 days (interquartile
range 16.7-25.2 days), excluding the 4 patients who died
and the 4 patients who were transferred to another hospital
for convalescence. The median follow-up for group A pa-
tients was 4 months (interquartile range 3-9.2 months). No
further sternal complications were encountered at follow-
up.
Group B had methicillin-resistant Staphylococcus aureus
cultured in 5 cases (38%). Among the patients in group B,
17% had diabetes, 83% had internal thoracic artery har-
vested (17% bilaterally), mean body mass index was 31.8
5.8 kg/m2, and immunosuppressive therapy was used in 1
TABLE 1. Preoperative patient data
Group A Group B
Age (y, mean  SD) 65.6 12.3 67.2 11.8
Body mass index (kg/m2, mean  SD) 30.9 3.7 31.8 5.8
Male (%) 57% 75%
Diabetes (%) 21% 17%
Resternotomy (%) 7% 17%
Elective surgery (%) 93% 92%
Left internal thoracic artery (%) 86% 67%
Bilateral internal thoracic arteries 0% 17%
Impaired left ventricular function (%) 36% 58%
Figure 1. Sternal wound of 39-year old woman who underwent
successful pulmonary thromboendarterectomy but developed
poststernotomy mediastinitis.
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case (Tables 1 and 2). Infection was diagnosed at a median
of 9 days (interquartile range 7-15 days) after the operation,
and duration of VAC treatment was a median of 8 days
(interquartile range 5.5-18 days). A healed, stable sternum
was achieved in 10 cases, with treatment failure in 2 cases
and death in another. The median hospital stay was 29 days
(interquartile range 25.8-38.2 days), excluding the 2 pa-
tients transferred to another hospital and the 1 who died.
The median follow-up at 8 months (interquartile range
4.5-18.5 months) did not reveal any problems in those with
a stable, healed sternum at hospital discharge. Overall (in
both groups A and B), 70% of the patients left the hospital
with a satisfactorily healed scar.
Figures 1 through 3 illustrate the changes in a wound
with poststernotomy mediastinitis in a patient who under-
went pulmonary thromboendarterectomy after use of the
VAC technique.
Before VAC insertion, the surgeon’s preferred method of
treatment for poststernotomy mediastinitis was sternal de´-
bridement and rewiring, followed by closed irrigation with
rifampin antibiotic solution (INN: rifampicin). This was
used in 13 patients during the 1-year period before VAC use
commenced. The infection rate for that year was 0.04%
(n  13/310). The treatment failure rate was 30.7% (n 
4/13), necessitating further interventions. In 2 of these pa-
tients, further de´bridement was carried out and reconstruc-
tion with a myocutaneous flap was performed to restore
chest stability. Four patients died of poststernotomy medi-
astinitis during that period (30.7%). Excluding the patients
who died (n  4) and the patients who were transferred to
another hospital (n  3), the median hospital stay was 35.5
days (29.7-45.7 days).
The overall cost per patient for the VAC treatment was
$16,400, as compared with $20,000 for the sternal rewiring
and closed irrigation treatment.
Discussion
Severe infections in cardiac surgery, although rare,2 con-
tinue to burden the health care delivery service in terms of
morbidity, mortality, and demands on personnel and cost.7
Treatment is usually prolonged, involving multiple trips to
the operating room and the need for general anesthesia.
VAC is an addition to the armamentarium in the man-
agement of severe wound infections, and it several advan-
tages relative to previous treatment strategies. VAC was
initially described by Davydov and colleagues8 and success-
Figure 2. Same patient after 48 hours of VAC applied to wound.
Note healthy granulation tissue.
Figure 3. Sternal wound of same patient after VAC application for
2 weeks. Wound is almost completely healed by secondary
intention with stable sternum.
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fully adapted for surgical wound management by Morykwas
and associates.9
The technique for VAC application has been described
previously.4,5 The mechanisms of action include an increase
in local blood flow, reductions of tissue edema and bacterial
colonization rates, removal of chronic wound fluid and
necrotic tissue, wound closure, and prevention of wound
dehydration by the occlusive dressing.10 Negative pressure
has been shown to increase dermal blood flow provided that
it does not exceed 200 mm Hg.10 This may be due to a direct
mechanical effect of sucking blood through the blood ves-
sels. Topical negative pressure reduces tissue edema by
removal of the interstitial fluid. A fall in bacterial count has
also been noted with the application of topical negative
pressure11; this effect may represent direct microbial re-
moval or may be secondary to improved local blood supply.
The extraction of chronic wound fluid promotes healing by
eliminating matrix metalloproteinases, which have been
shown to suppress endothelial cell and fibroblast prolifera-
tion.12 Last but not least, topical negative pressure causes
reverse tissue expansion and hence promotes wound clo-
sure, a concept referred to by pundits as “mechanical
creep.”13
An additional benefit from the use of VAC in the patients
described here was that the dressing changes were all per-
formed without the need for general anesthesia (except
when VAC was applied at time of initial wound de´bride-
ment with the patient already under general anesthesia).
Dressing changes were carried out every 48 hours at mini-
mum, which reduced the workload of the attending medical
staff. The negative-pressure regimen that was followed in-
cluded continuous suction for the first 48 hours followed by
an intermittent suction (cycles of 5 minutes on and 2 min-
utes off) thereafter at a negative pressure not exceeding 125
mm Hg. There is also the possibility of sending the patient
home with a portable version of the device.
The patients described in this series had significant pre-
morbid risk factors for wound complication, especially se-
vere obesity, use of internal thoracic artery, and diabetes.
We are limited in our efforts to deliver the best available
care by achieving a balance with the use of internal thoracic
arteries (survival and patency benefits) in patients with
obesity, diabetes, and immunosuppression.
Overall, a 70% success rate (healed wound) was
achieved with the use of VAC. This is highly significant in
this group of patients, among whom morbidity and mortal-
ity are usually high. The overall cost per patient of the VAC
system was nearly $4000 cheaper than that associated with
a closed irrigation system at our institution. This difference
reflects the reduced costs in operating room time, intensive
care stay, and hospital stay. In our series, the median hos-
pital stays were 20 days for group A and 29 days for group
B, as compared with 35.5 days for the closed irrigation
system patients. A similar trend is reflected in previously
published data.6 In that series, patients stayed a median of
40.5 days after the initiation of therapy for poststernotomy
mediastinitis, which was closed drainage and irrigation.
It has now become clear that VAC is a highly reliable
and reproducible treatment modality. We therefore intend to
compare it with other strategies in a randomized, controlled
study.
Conclusion
VAC treatment for severe wound infections in cardiac sur-
gery has now become an established management modality.
It has a reasonable success rate and is both reliable and
reproducible. Its cost is acceptable when mortality, morbid-
ity, demands on medical personnel, and end results are
taken into consideration.
We are grateful to Ms F. Carey from the audit and clinical
governance department for the data concerning the closed irriga-
tion system group of patients and to Mrs R. Thornton, senior
management accountant, for the costs of hospitalization and oper-
ating room time.
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